Robust Potential for Growth in China's Pharmacovigilance Sector
As the healthcare landscape in China continues to evolve, the pharmacovigilance market emerges as a critical component in ensuring drug safety. The China pharmacovigilance market is anticipated to expand significantly, projected to achieve a volume of 1,170.06 million USD by 2035, representing a remarkable CAGR of 8.62% from 2024. This growth trajectory reflects the increasing importance of...
0 Yorumlar 0 hisse senetleri 5 Views 0 önizleme